Volume 7, Issue 12:New Options for Patients with “Hard-To-Treat” Hepatitis C Infection

e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 7, Issue 12)

 

Target Audience

Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to: 

  • Describe the key clinical considerations when selecting a retreatment regimen for patients who have failed previous therapy with DAA agents. 
  • Describe the key clinical considerations when selecting a retreatment regimen for patients who have failed previous therapy with peginterferon and ribavirin.
  • Describe the key clinical considerations when selecting a treatment regimen for patients with renal impairment.
Course summary
Available credit: 
  • 0.50 ANCC
  • 0.50 Attendance
Registration opens: 
01/25/2018
Registration closes: 
01/24/2020
Cost:
$0.00
Ira M. Jacobson, MD
Director of Hepatology
New York University School of
Medicine
New York, NY

Available Credit

  • 0.50 ANCC
  • 0.50 Attendance

Price

Cost:
$0.00
Please login or register to take this course.